JFG
MDGL icon

Jefferies Financial Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Jefferies Financial Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340K Sell
633
-1,467
-70% -$751K ﹤0.01% 1349
2026
Q1 		$1.1M Sell
2,100
-200
-9% -$95.6K 0.01% 890
2025
Q4 		$1.34M Buy
+2,300
New +$1.17M 0.01% 955
2025
Q1 		– Sell
-250
Closed -$77.1K – 1852
2024
Q4 		$77.1K Sell
250
-102
-29% -$28.7K ﹤0.01% 1480
2024
Q3 		$74.7K Buy
+352
New +$90.1K ﹤0.01% 1321
2023
Q3 		– Sell
-274
Closed -$51.6K – 1830
2023
Q2 		$63.3K Sell
274
-1,079
-80% -$292K ﹤0.01% 1530
2023
Q1 		$328K Buy
+1,353
New +$369K ﹤0.01% 1208

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jefferies Financial Group's MDGL Position: Q2 2026 in Review

Jefferies Financial Group reduced its Madrigal Pharmaceuticals (MDGL) stake by 70% in Q2 2026, selling an estimated $751K and leaving 633 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #1349.

Jefferies Financial Group first reported a position in MDGL in Q1 2023 and has held it in 7 quarters since. The position peaked at $1.34M in Q4 2025. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Jefferies Financial Group held 633 shares of Madrigal Pharmaceuticals worth $340K as of Q2 2026.
  • Jefferies Financial Group sold 1,467 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $751K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #1349 holding.
  • Jefferies Financial Group first reported a position in Madrigal Pharmaceuticals in Q1 2023 and has held it in 7 quarters since.
  • Jefferies Financial Group's Madrigal Pharmaceuticals position peaked at $1.34M in Q4 2025.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.